Apr 06, 2020
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren® Arthritis Pain
Apr 02, 2020
Carlson Law Firm Assisting Clients Suffering from Zantac-Related Cancer
Apr 01, 2020
Media Briefing: FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
Mar 31, 2020
Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections
Mar 25, 2020
Ibuprofen (CAS 15687-27-1) Market Research Report 2020 - ResearchAndMarkets.com
Mar 25, 2020
Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusivity in the U.S. for Lopinavir/Ritonavir to Help Ensure Wider Availability to Meet Potential COVID-19 Patient Needs
Mar 23, 2020
Flexipharm Austrading Announces Product Update on Arsenic Trioxide Phebra
Mar 20, 2020
Information Update - No scientific evidence that ibuprofen worsens COVID-19 symptoms
Mar 17, 2020
Caldolor® Demonstrates Favorable Safety Profile In Newborns
Mar 10, 2020
Progress of the Small Sample Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
Mar 09, 2020
AbbVie Partnering with Global Authorities to Determine Efficacy of HIV Drug in Treating COVID-19
Feb 28, 2020
FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States
Feb 28, 2020
FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States
Feb 28, 2020
Are We Doing Enough To Protect Our Hearts?: Millions Of Patients Face Continued Cardiovascular Risk
Feb 27, 2020
Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx(TM) For The Acute Treatment of Migraine
Feb 27, 2020
Avion Pharmaceuticals' new gout prophylaxis product, GLOPERBA®, is the first and only liquid form of colchicine (1,2)
Feb 26, 2020
Actinium Announces Actimab-A Plus 7+3 Combination Trial for Newly Diagnosed Acute Myeloid Leukemia Patients
Feb 19, 2020
Kowa Achieves Goal Of Randomizing 10,000 Patients Into Landmark "PROMINENT" Cardiovascular Outcomes Study Of K-877 (Pemafibrate)
Feb 18, 2020
Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea
Feb 17, 2020
FDA approves GSK's Voltaren Arthritis Pain for over-the-counter use in the United States